🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Scleroderma › Illinois › Chicago

Qorannoo klinikaalii Diffuse Scleroderma Chicago, IL keessatti

Qorannoo 7 Diffuse Scleroderma f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

Namoota walitti qabaa jiraSadarkaa 2
  • University of Chicago Hospitals, Chicago
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06470048

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Namoota walitti qabaa jiraSadarkaa 1
  • The University of Chicago Medical Center, Chicago
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • GSK Investigational Site, Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05878717

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Namoota walitti qabaa jiraSadarkaa 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

Namoota walitti qabaa jiraSadarkaa 2
  • The University of Chicago Medical Center (UCMC), Chicago
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Namoota walitti qabaa jiraSadarkaa 2/3
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Nkarta Investigational Site, Chicago
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06733935

Qorannoo Diffuse Scleroderma magaalota biroo keessatti

Qorannoo biroo Chicago keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.